A Study of Tucidinostat in Combination With Sintilimab and Bevacizumab in MSS/pMMR Colorectal Cancer Patients
Clinical trial NCT06497985 · RECRUITING
Trial details
- NCT number
- NCT06497985
- Sponsor
- Chipscreen Biosciences, Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-06
- Primary completion
- 2028-05-31
- Enrollment
- 430
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.